NCT01660295View on ClinicalTrials.gov

Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2012

Conditions
Renal Insufficiency
Interventions
DRUG

Certoparin 3,000 IU Once Daily

Certoparin 3,000 IU subcutaneous injection once daily

DRUG

Certoparin 3,000 IU Twice a Day

Certoparin 3,000 IU subcutaneous injection twice a day

DRUG

Certoparin 8,000 IU Once Daily

Certoparin 8,000 IU subcutaneous injection once daily

DRUG

Certoparin 8,000 IU Twice a Day

Certoparin 8,000 IU subcutaneous injection twice a day

Trial Locations (1)

12

DRC Drug Research Center Ltd., H-8230 Balatonfüred, H-8230 Balatonfüred

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY